Company History
Company Introduction
Kanova Biopharma was founded by a world-renowned immunologist in Nov. 2015. Based on its cutting-edge research in immunology, Kanova focuses on developing first-in-class therapeutic antibodies or innovative combination therapies to treat autoimmune diseases and cancer.
“Innovation, precision, quality and focus” is the core value of our company. Through our internal research and external collaboration, we aim to accelerate the R&D process of innovative antibody medicines. We root in China with the global vision to discover and develop novel treatments for cancer and autoimmune diseases.
The company has developed a rich pipeline in autoimmune diseases and immuno-oncology based on its proprietary technology platforms in the past five years. These products will help to address the rapidly growing, unmet medical needs in China and around the world
Coporate Vision
As a clinical stage biotech company based on innovative immunology research, we root in China with the global vision to develop safe and highly efficacious novel treatments for autoimmune diseases and cancer.
Core Positioning
Based on our proprietary antibody research and technology platforms, and guided by our core strength in IP development and innovation, we aim to lead the development of new treatments based on novel targets in mono or combination therapies.
Beijing Address: A203, Zhongguancun Biomedical Park, No.5, Development Road, Haidian District, Beijing
Zhejiang Address: Floor 8, Building 7, Dongsheng Huigu, 1299 Kehai Avenue, Keqiao District, Shaoxing City, Zhejiang Province
Contact Phone:010-82176552
E-mail:hr@kanovabiopharma.com